* Prestige Consumer Healthcare Inc PBH.N reported
quarterly
adjusted earnings of $1.06 per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $1.04. The mean expectation of
six analysts for the quarter was for earnings of $1.04 per
share. Wall Street expected results to range from $1.04
to $1.05 per share.
* Revenue rose 2.6% to $282.74 million from a year ago;
analysts
expected $280.25 million.
* Prestige Consumer Healthcare Inc's reported EPS for the
quarter
was $1.06.
* The company reported quarterly net income of $53.05
million.
* Prestige Consumer Healthcare Inc shares had risen by 2.8%
this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Prestige Consumer
Healthcare Inc is $71.00
This summary was machine generated from LSEG data February 8 at
02:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 1.04 1.06 Beat
Sep. 30 2023 1.07 1.07 Met
Jun. 30 2023 1.01 1.06 Beat
Mar. 31 2023 1.04 -4.83 Missed